Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy
- PMID: 35278004
- DOI: 10.1002/mds.28976
Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy
Abstract
Background: Aggregation of α-synuclein (oligomeric α-syn) has been considered as the pathological hallmark of Parkinson's disease (PD) and multiple system atrophy (MSA). Studies showed oligomeric α-syn/total α-syn ratio was increased in the saliva of patients with PD, suggesting that seeding activity of salivary oligomeric α-syn may be a novel biomarker for the diagnosis of PD and MSA.
Objective: This study aimed to evaluate the diagnostic value of salivary α-syn seeding activity in patients with PD and MSA.
Methods: A total of 75 patients with PD, 18 patients with MSA, and 36 nonneurodegenerative healthy control subjects underwent salivary α-syn real-time quaking-induced conversion (RT-QuIC) assay.
Results: Salivary α-syn RT-QuIC assay distinguished patients with PD with 76.0% sensitivity (95% confidence interval [CI], 66.1-85.9) and 94.4% specificity (95% CI, 86.6-100.0). RT-QuIC assay sensitivity reached 61.1% (95% CI, 36.2-86.1) in patients with MSA. No significant differences were observed in the diameter of salivary α-syn fibrils examined by electron microscopy and in thioflavin T fluorescence intensity of salivary α-syn fibrils detected by RT-QuIC assay between patients with PD and MSA. Notably, the lag phase of RT-QuIC assay from patients with PD was significantly shorter than that of patients with MSA, which might be clinically applicable to the discrimination between PD and MSA.
Conclusions: Salivary α-syn seeding activity may serve as a novel biomarker for the clinical diagnosis of PD and MSA.© 2022 International Parkinson and Movement Disorder Society © 2022 International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; RT-QuIC; multiple system atrophy; real-time quaking-induced conversion assay; saliva; seed amplification assay.
© 2022 International Parkinson and Movement Disorder Society.
Similar articles
-
Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy.Parkinsonism Relat Disord. 2024 Oct;127:107088. doi: 10.1016/j.parkreldis.2024.107088. Epub 2024 Aug 5. Parkinsonism Relat Disord. 2024. PMID: 39111257
-
Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.Transl Neurodegener. 2025 Feb 7;14(1):7. doi: 10.1186/s40035-025-00469-6. Transl Neurodegener. 2025. PMID: 39920796 Free PMC article.
-
Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.Mol Neurodegener. 2021 Dec 11;16(1):82. doi: 10.1186/s13024-021-00491-y. Mol Neurodegener. 2021. PMID: 34895275 Free PMC article.
-
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.Exp Gerontol. 2024 Mar;187:112366. doi: 10.1016/j.exger.2024.112366. Epub 2024 Feb 6. Exp Gerontol. 2024. PMID: 38280659 Review.
-
Neuropathology and molecular diagnosis of Synucleinopathies.Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z. Mol Neurodegener. 2021. PMID: 34922583 Free PMC article. Review.
Cited by
-
Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.Viruses. 2022 Aug 31;14(9):1940. doi: 10.3390/v14091940. Viruses. 2022. PMID: 36146746 Free PMC article. Review.
-
Clinical application of prion-like seeding in α-synucleinopathies: Early and non-invasive diagnosis and therapeutic development.Front Mol Neurosci. 2022 Oct 10;15:975619. doi: 10.3389/fnmol.2022.975619. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36299857 Free PMC article. Review.
-
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9. Nat Commun. 2024. PMID: 38969680 Free PMC article. Review.
-
Toward a biological definition of neuronal and glial synucleinopathies.Nat Med. 2025 Feb;31(2):396-408. doi: 10.1038/s41591-024-03469-7. Epub 2025 Jan 30. Nat Med. 2025. PMID: 39885358 Review.
-
α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.Trends Biotechnol. 2024 Jul;42(7):829-841. doi: 10.1016/j.tibtech.2024.01.007. Epub 2024 Feb 23. Trends Biotechnol. 2024. PMID: 38395703 Free PMC article. Review.
References
-
- Bargar C, Wang W, Gunzler SA, et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol Commun 2021;9(1):62
-
- Mammana A, Baiardi S, Quadalti C, et al. RT-QuIC detection of pathological α-Synuclein in skin punches of patients with Lewy body disease. Mov Disord 2021;36(9):2173-2177.
-
- Manne S, Kondru N, Jin H, et al. α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients. Mov Disord 2020;35(2):268-278.
-
- Shahnawaz M, Mukherjee A, Pritzkow S, et al. Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy. Nature 2020;578(7794):273-277.
-
- Wang Z, Becker K, Donadio V, et al. Skin α-Synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol 2020;78(1):30-40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous